GEMAYEL GEORGES
SEC Form 4 insider trading activity
GEMAYEL GEORGES has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 9, 2026.
On the most recent filing, GEMAYEL GEORGES is listed as Director at SUPERNUS PHARMACEUTICALS, INC. Inside the rolling window, GEMAYEL GEORGES reported no open-market purchases and 2 open-market sales totaling $1.0M in SUPN. The largest disclosed transaction in the window is a sale of 10,000 SUPN shares on Mar 5, 2026, worth $537K.
Companies traded
Other insiders at SUPN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GEMAYEL GEORGES made?
GEMAYEL GEORGES has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does GEMAYEL GEORGES trade?
GEMAYEL GEORGES has filed SEC Form 4 disclosures for 1 company, including SUPN.
When was GEMAYEL GEORGES's most recent SEC Form 4 filing?
GEMAYEL GEORGES's most recent SEC Form 4 filing on Tracefour is dated Mar 9, 2026.
What is GEMAYEL GEORGES's total buy and sell value in the current window?
Inside the rolling retention window, GEMAYEL GEORGES bought $0 and sold $1.0M based on SEC Form 4 filings.
What was GEMAYEL GEORGES's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 SUPN shares on 2026-03-05, worth $537K, per SEC Form 4 filings.